Investigators assessed sex differences in the risk for major cardiovascular events (MACE+) among patients with anemia of non-dialysis chronic kidney disease (CKD).

The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...

The division of myelodysplastic syndromes (MDS) into low-risk and high-risk categories guides prognosis and treatment, with patients who have lower-risk disease typically receivin ...

What Are Biomarkers? A Guide to Understanding the Health Indicators Key Takeaways: Biomarkers — aka biological markers — are ...

Using a deep learning AI model, researchers identified the first-of-its-kind biomarker of chronic stress detectable through routine imaging, according to research being presented next week at the ...

CNW/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay Pharmaceutical Group (DPG), is dedicated to providing patients with rare diseases access to orphan drugs. Medunik USA is ...

Prevalence of hearing loss was significantly higher for patients with diagnosis of type 2 diabetes for more than 10 years.

Agios Pharmaceuticals said on Wednesday its sickle cell drug met one of its two main goals in a late-stage study ​of patients aged 16 and older, but failed to show a statistically ‌significant ...

Can you benefit from light therapy? It depends. Treatments range from nonsensical to possibly useful to those proven to be effective.

Results from pre-clinical studies conducted by scientists at Memorial Sloan Kettering Cancer Center show delayed leukemic ...

Stenting, but not endarterectomy, significantly reduced stroke risk compared with intensive medical therapy alone.